VTRO (Vitro Biopharma) Days Inventory: 30.93 (As of Oct. 2022) — 94% Below Median


What is Vitro Biopharma Days Inventory?

Vitro Biopharma VTRO Days Inventory is 30.93 as of Oct. 2022, which is 94% below its 10-year median of 530.45. The stock has 6 warning signs investors should review.

Days Inventory is also known as Days Sales of Inventory (DSI). Vitro Biopharma's Average Total Inventories for the three months ended in Oct. 2022 was $0.20 Mil. Vitro Biopharma's Cost of Goods Sold for the three months ended in Oct. 2022 was $0.59 Mil. Hence, Vitro Biopharma's Days Inventory for the three months ended in Oct. 2022 was 30.93.

The historical rank and industry rank for Vitro Biopharma's Days Inventory or its related term are showing as below:

VTRO' s Days Inventory Range Over the Past 10 Years
Min: 74.35   Med: 530.45   Max: 1216.67
Current: 123.74

During the past 13 years, Vitro Biopharma's highest Days Inventory was 1216.67. The lowest was 74.35. And the median was 530.45.

VTRO's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 183.195 vs VTRO: 123.74

Vitro Biopharma's Days Inventory declined from Oct. 2014 (93.23) to Oct. 2022 (30.93).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Vitro Biopharma's Inventory Turnover for the three months ended in Oct. 2022 was 2.95.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vitro Biopharma's Inventory-to-Revenue for the three months ended in Oct. 2022 was 0.06.


Vitro Biopharma  (AMEX:VTRO) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Vitro Biopharma's Inventory Turnover for the three months ended in Oct. 2022 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vitro Biopharma's Inventory to Revenue for the three months ended in Oct. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Vitro Biopharma Days Inventory Related Terms


Vitro Biopharma Days Inventory Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Days Inventory Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 372.93 443.21 93.86 74.35 123.74

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.23 110.80 23.46 18.59 30.93

VTRO vs : Days Inventory Comparison

For the Biotechnology subindustry, Vitro Biopharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitro Biopharma Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vitro Biopharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Vitro Biopharma's Days Inventory falls into.



Vitro Biopharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vitro Biopharma's Days Inventory for the fiscal year that ended in Oct. 2022 is calculated as

Days Inventory (A: Oct. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Oct. 2021 ) + Total Inventories (A: Oct. 2022 )) / count ) / Cost of Goods Sold (A: Oct. 2022 )*Days in Period
=( (0.118 + 0.28) / 2 ) / 0.587*365
=0.199 / 0.587*365
=123.74

Vitro Biopharma's Days Inventory for the quarter that ended in Oct. 2022 is calculated as:

Days Inventory (Q: Oct. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Oct. 2021 ) + Total Inventories (Q: Oct. 2022 )) / count ) / Cost of Goods Sold (Q: Oct. 2022 )*Days in Period
=( (0.118 + 0.28) / 2 ) / 0.587*365 / 4
=0.199 / 0.587*365 / 4
=30.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 30.93 mean?
Vitro Biopharma (VTRO) has a Days Inventory of 30.93 as of Oct. 2022. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vitro Biopharma and its competitors. This is 94% below median its historical median of 530.45. Over the past decade, Vitro Biopharma's Days Inventory has ranged from 74.35 to 1,216.67.
Is Vitro Biopharma's Days Inventory too high?
Vitro Biopharma's current Days Inventory of 30.93 is 94% below median its 10-year median of 530.45. Over the past 10 years, this metric has ranged from a low of 74.35 to a high of 1,216.67. The Biotechnology industry median Days Inventory is 183.20. Vitro Biopharma's value of 30.93 is 83.1% below this industry median.
How does Vitro Biopharma's Days Inventory compare to ?
Vitro Biopharma's Days Inventory of 30.93 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.20. Vitro Biopharma's value of 30.93 is 83.1% below this benchmark. Historically, Vitro Biopharma's own Days Inventory has ranged from 74.35 to 1,216.67 over the past decade. While the company's 10-year median is 530.45 vs. the industry median of 183.20, Vitro Biopharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitro Biopharma's current Days Inventory of 30.93 is 83.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vitro Biopharma and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitro Biopharma's current Days Inventory is 30.93, which is 94% below median its own 10-year median of 530.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Days Inventory of 30.93. The current Days Inventory is 30.93, which is 94% below median its 10-year median of 530.45 and 83.1% below the Biotechnology industry median of 183.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Days Inventory is 30.93 as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.